4//SEC Filing
Meyer Andrew Hollman 4
Accession 0001864159-26-000002
CIK 0001817713other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 9:00 PM ET
Size
4.9 KB
Accession
0001864159-26-000002
Insider Transaction Report
Form 4
Meyer Andrew Hollman
Chief Business Officer
Transactions
- Sale
Common Stock
2026-01-02$13.73/sh−1,879$25,799→ 83,095 total
Footnotes (1)
- [F1]The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0001864159
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 9:00 PM ET
- Size
- 4.9 KB